These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35644522)

  • 1. Apolipoprotein A5, a unique modulator of fasting and postprandial triglycerides.
    May-Zhang L; Liu M; Black D; Tso P
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Sep; 1867(9):159185. PubMed ID: 35644522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.
    Sharma V; Ryan RO; Forte TM
    Biochim Biophys Acta; 2012 May; 1821(5):795-9. PubMed ID: 22209939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway.
    Li R; Chen LZ; Zhao W; Zhao SP; Huang XS
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1173-8. PubMed ID: 27544029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
    Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design).
    Kim JY; Kim OY; Koh SJ; Jang Y; Yun SS; Ordovas JM; Lee JH
    J Am Coll Nutr; 2006 Aug; 25(4):340-7. PubMed ID: 16943456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen lowers triglyceride via regulating hepatic APOA5 expression.
    Luo F; Guo Y; Ruan GY; Peng R; Li XP
    Lipids Health Dis; 2017 Apr; 16(1):72. PubMed ID: 28376804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism.
    Forte TM; Ryan RO
    Curr Drug Targets; 2015; 16(12):1274-80. PubMed ID: 26028042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
    Zhao SP; Li R; Dai W; Yu BL; Chen LZ; Huang XS
    PLoS One; 2017; 12(9):e0184949. PubMed ID: 28934253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact.
    Guardiola M; Ribalta J
    Curr Atheroscler Rep; 2017 Jul; 19(7):30. PubMed ID: 28500476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.
    Hubacek JA
    Gene; 2016 Oct; 592(1):193-199. PubMed ID: 27496343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metformin reduces plasma triglycerides in ob/ob obese mice via inhibiting the hepatic apoA5 expression].
    Huang X; Li R; Chen L; Dai W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 42(12):1389-1394. PubMed ID: 29317579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
    Jakel H; Nowak M; Helleboid-Chapman A; Fruchart-Najib J; Fruchart JC
    Ann Med; 2006; 38(1):2-10. PubMed ID: 16448983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.
    Dai W; Zhang Z; Yao C; Zhao S
    Lipids Health Dis; 2019 Dec; 18(1):220. PubMed ID: 31836003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V.
    Bertoccini L; Sentinelli F; Incani M; Bailetti D; Cimini FA; Barchetta I; Cavallo MG; Cossu E; Lenzi A; Loche S; Baroni MG
    Lipids Health Dis; 2017 Sep; 16(1):179. PubMed ID: 28927406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol, Carbohydrate, and Calcium Intakes and Smoking Interactions with APOA5 rs662799 and rs2266788 were Associated with Elevated Plasma Triglyceride Concentrations in a Cross-Sectional Study of Korean Adults.
    Park S; Kang S
    J Acad Nutr Diet; 2020 Aug; 120(8):1318-1329.e1. PubMed ID: 32335043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
    Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
    J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
    Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
    Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A5 and hypertriglyceridemia in Prague hypertriglyceridemic rats.
    Kadlecová M; Hojná S; Bohuslavová R; Hubácek JA; Zicha J; Kunes J
    Physiol Res; 2006; 55(4):373-379. PubMed ID: 16238453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.